Newly released advertorials
|
Comprehensive food safety in Kuopio - Februari 24, 2010 During the latest years, the safety of food has become an increasingly interesting
global issue. It has become a source of concern as the amount of information about
the foodborne diseases continues to grow and cases of foodborne illness occur
nearly in all countries.
|
Efficacy to healthcare with wireless technology - Februari 24, 2010 As the population grows older and labour costs become more expensive, we will have
to adopt novel operational modes, products and services to health and wellbeing. The
traditional healthcare system needs to be changed into an integrated ICT-based
system.
|
Human metabolite identification - Februari 24, 2010 The recent regulatory guidance documents issued by the FDA and ICH,
highlight that a renewed focus is needed for a thorough understanding
of the identity of human metabolites as early as possible in the R & D
process.
|
New hope for BV patients - Februari 24, 2010 There is a huge unmet medical need for improved products to treat Bacterial
Vaginosis (BV), the most common gynaecological infection.
|
M&A – The trials and tribulations - Februari 21, 2010 Former Schering & Plough CEO speaks out about the pharmaceutical Industry . Where they went wrong and the solutions, which lead to the successful sale.
With the recent announcement of the Merck & Co acquisition of Schering & Plough, Fred Hassan the former Chief Executive Officer has been speaking to Meettheboss.TV on the future of the pharmaceutical Industry, mergers, acquisitions and the resistance felt?
|
Finland supports national bioscience technology platforms with 45 million € through Biocenter Finland - Februari 18, 2010 Biocenter Finland was established in 2006 as a joint effort of six
biocenters operated by six Universities (Helsinki, Kuopio, Oulu,
Tampere and Turku, and the Abo Akademi University). The Institute for
Molecular Medicine Finland (FIMM) has signed a collaboration agreement
with Biocenter Finland and some research institutes are also closely
affiliated with biocenters in specific fields. |
Biosquare 2010, The first bioconvergence partnering conference - December 8, 2009 34 hours of intense partnering opportunities |
Encuentro Scientific & Business Meeting - December 4, 2009 |
15th Annual International Partnering Conference – BIO-Europe 2009 - October 3, 2009 BIO-Europe is Europe’s largest partnering conference, serving the global biotechnology industry. The conference annually attracts international leaders from biotech, pharma and finance along with the most promising start-ups and emerging companies. It is the “must attend” event for getting busines done in the biotech industry. |
3rd Annual International Partnering Conference – BioPharm America 2010 BioPharm America is the premier stand-alone partnering event in North America. Based on the same proven formula as EBD Group’s leading European partnering conference, the event attracts top international and regional companies for three days of productive networking and dealmaking. |
SBW/Biodix at your service! - September 15, 2009 As an introductory campaign we are pleased to offer an EXPLORATORY COMPLEX PROTEOMICS PROFILING STUDY.
|
Prepare to be Inspired! - September 15, 2009 Submit an abstract and register now for 50+ Keystone Symposia conferences taking place January through June 2010 in a wide variety of life science disciplines.
|
Strategic R&D Collaboration- & Portfolio (Project)
Management in Pharma & Biotech The pharma and biotech companies are currently under pressure due to the rising costs, as well as increasing regulatory demands and missing blockbusters. By losing patent licenses Collaborations, (Bio) partnering and licensing will be the essential strategy for successful companies in a market under pressure. Smarter and more efficient project and portfolio management through collaborations and partnering, will be instrumental in driving progress both short and long term within your establishment.
|
How to build a chemical universe - May 22, 2009 Peter Halkjaer Knudsen tells us about recent developments in how to build up a strong chemical compound collection, yielding an attractive cost-benefit ratio when screening.
|
Automated Cloning and Expression in the Service Laboratory - May 22, 2009 A Tecan Liquid Handling Robot Simplifies Applications in the High Throughput Expression Laboratory at the University of York. This Service Laboratory Specializes in Large-Scale Cloning and Protein Expression.
|
Science Please! - April 13, 2009 Pharma and Biotech Companies are confronted with increasing global competition and rising research and development costs. These companies look for new, more open, models of innovation. Also, as an effect of the financial crisis, companies are making their workforce more flexible and focus on collaboration with external partners, whether suppliers, customers or universities, to keep ahead of the game and get new products to the market before their competitors do.
|
The leading technology companies - March 18, 2009 shareTo stay on top the leadingcompanies spend huge amountsof money to gatherinformation annually.
|
Semi-virtual operating policy - March 3, 2009 The drug discovery company Medeia Therapeutics Ltd. has not invested in laboratories of their own, instead they have outsourced their research activities to universities and companies in Finland and abroad.
|
Unexploited synergies within Life Sciences in the Baltic Sea Region - December 21, 2008 The future success of the Baltic Sea Region greatly depends on the region’s ability to overcome and turn the current challenges into new opportunities. Key stakeholders such as public authorities, research institutions, private life science companies, cluster organizations and investors should be encouraged to form partnerships in order to improve sharing of knowledge and resources. This will promote taking benefits from unexploited synergies in the countries around the Baltic Sea – Top of Europe. |
- Positive move to help biotech companies through distressing financial times: NORWEGIAN GOVERNMENT SUPPORTS CLINICAL TRIALS IN CANCER - December 9, 2008 London, December 9th: Oslo Cancer Cluster today announced that the Norwegian Government is to strengthen early phase clinical trials in cancer at the Norwegian Radium Hospital, as well as other clinical research units in Norway. This move is part of a deliberate strategy to enhance innovation in biotechnology. |
Pharmaceutical Profiles supports new-generation HCV drug development DRUG DEVELOPMENT It is estimated that 180 million people are infected with HCV worldwide. The market for HCV therapeutics currently stands at USD 3 billion but has the potential to rise to over USD 10 billion with the introduction of new agents. New-generation HCV drugs look set to provide significantly improved efficacy compared to current combination treatments. |
Fishing for answers - September 22, 2008 Research at the scale of cGRASP, one of the largest marine biotechnology projects in the world, is possible only through the combined efforts of international leaders in salmonid genomics, pooling the resources Author Brian Yates Project Manager cGRASP project of four countries to achieve globally significant results. |
A new 384-channel head for Tecan’s Freedom EVO® platforms - May 30, 2008 Tecan is launching the MultiChannel Arm 384 for its Freedom EVO® workstations, offering higher productivity to automated liquid handling processes in pharmaceutical and biotechnology research applications. The new 384-channel head can be mounted onto the Freedom EVO 100, 150 or 200 platforms, increasing the efficiency and speed of pipetting processes for better throughput, and delivering a greater level of flexibility. |